Blueprint Medicines Corp financial data

Symbol
BPMC on Nasdaq
Industry
Pharmaceutical Preparations
Location
45 Sidney Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 407 % -32%
Quick Ratio 10.9 % -36.4%
Debt-to-equity 350 % +179%
Return On Equity -121 % -20.4%
Return On Assets -26.8 % +39.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.6M shares +3.56%
Common Stock, Shares, Outstanding 62.6M shares +3.61%
Entity Public Float 3.8B USD +26.6%
Common Stock, Value, Issued 63K USD +5%
Weighted Average Number of Shares Outstanding, Basic 61.6M shares +2.42%
Weighted Average Number of Shares Outstanding, Diluted 63.8M shares +6.11%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 404M USD -17%
Costs and Expenses 723M USD -4.92%
Nonoperating Income (Expense) 153M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -288M USD +50%
Income Tax Expense (Benefit) 628K USD -88.7%
Net Income (Loss) Attributable to Parent -288M USD +50.4%
Earnings Per Share, Basic -4.77 USD/shares +50.9%
Earnings Per Share, Diluted -4.82 USD/shares +50.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 113M USD -33.2%
Accounts Receivable, after Allowance for Credit Loss, Current 60M USD +100%
Inventory, Net 30.9M USD +76.6%
Assets, Current 777M USD -13.7%
Property, Plant and Equipment, Net 41.9M USD +24.3%
Operating Lease, Right-of-Use Asset 71.2M USD -10.6%
Other Assets, Noncurrent 22.6M USD -34.5%
Assets 1.04B USD -14.9%
Accounts Payable, Current 4.93M USD -53.4%
Employee-related Liabilities, Current 20M USD +17.6%
Accrued Liabilities, Current 107M USD -1.34%
Contract with Customer, Liability, Current 7.25M USD +93.9%
Liabilities, Current 207M USD +19.6%
Contract with Customer, Liability, Noncurrent 4.64M USD -7.3%
Operating Lease, Liability, Noncurrent 78.5M USD -12.7%
Other Liabilities, Noncurrent 5.77M USD +85.9%
Liabilities 728M USD -9.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.85M USD +16.4%
Retained Earnings (Accumulated Deficit) -2.25B USD -14.7%
Stockholders' Equity Attributable to Parent 311M USD -25%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 311M USD -25%
Liabilities and Equity 1.04B USD -14.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -102M USD +17.4%
Net Cash Provided by (Used in) Financing Activities 67M USD
Net Cash Provided by (Used in) Investing Activities 77.1M USD -55.4%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 62.6M shares +3.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 49.8M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 124M USD -29.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14.3M USD +102%
Deferred Tax Assets, Valuation Allowance 775M USD +23.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 800M USD +22.7%
Operating Lease, Liability 93.7M USD -9.37%
Depreciation 7.7M USD +18.5%
Payments to Acquire Property, Plant, and Equipment 1.1M USD -57.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -288M USD +49.9%
Lessee, Operating Lease, Liability, to be Paid 116M USD -12.7%
Property, Plant and Equipment, Gross 80.5M USD +24.5%
Operating Lease, Liability, Current 12.2M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.8M USD +3.37%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.2M USD +2.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.9M USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.3M USD +3.73%
Deferred Tax Assets, Operating Loss Carryforwards 233M USD +20.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 19.8M USD +3.77%
Operating Lease, Payments 4.55M USD +3.2%
Additional Paid in Capital 2.57B USD +7.72%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.81M USD +30.6%
Share-based Payment Arrangement, Expense 93.7M USD -5.13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%